Vandria Doses First Subjects in VNA-318 Phase 1 Trial
18 Dec 2024 //
GLOBENEWSWIRE
Vandria Raises $30.7M For CNS Clinical Development Of VNA-318
21 Aug 2024 //
GLOBENEWSWIRE
Vandria Awarded ‚¬3.8M in Prestigious Innosuisse and Eurostars Grants
08 Feb 2024 //
GLOBENEWSWIRE